(Q38453207)

3 September 2017

title

Recurrent B-cell neoplasms after Rituximab therapy: an immunophenotypic and genotypic study (English)

1 reference

3 September 2017

1 reference

Peiguo G Chu

1

1 reference

3 September 2017

Yuan-Yuan Chen

2

1 reference

3 September 2017

Arturo Molina

3

1 reference

3 September 2017

Daniel A Arber

4

1 reference

3 September 2017

Lawrence M Weiss

5

1 reference

3 September 2017

publication date

1 December 2002

1 reference

3 September 2017

1 reference

3 September 2017

volume

43

1 reference

3 September 2017

issue

12

1 reference

3 September 2017

page(s)

2335-2341

1 reference

Treatment of B-cell non-Hodgkin's lymphoma with anti CD 20 monoclonal antibody Rituximab

3 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1080%2F1042819021000040044

Rituximab chimeric anti-CD20 monoclonal antibody therapy for relapsed indolent lymphoma: half of patients respond to a four-dose treatment program.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1042819021000040044

Treatment of patients with low-grade B-cell lymphoma with the combination of chimeric anti-CD20 monoclonal antibody and CHOP chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1042819021000040044

Acute lymphoblastic leukemia. Survey of immunophenotype, French-American-British classification, frequency of myeloid antigen expression, and karyotypic abnormalities in 210 pediatric and adult cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1042819021000040044

Detection of immunoglobulin kappa light chain rearrangements by polymerase chain reaction. An improved method for detecting clonal B-cell lymphoproliferative disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1042819021000040044

Antibodies reactive with the B1 molecule inhibit cell cycle progression but not activation of human B lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1042819021000040044

Adjuvant chemotherapy with CEF versus CMF for node-positive breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1042819021000040044

Loss of CD20 expression following treatment with rituximab (chimaeric monoclonal anti-CD20): a retrospective cohort analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1042819021000040044

Clonal selection of CD20-negative non-Hodgkin's lymphoma cells after treatment with anti-CD20 antibody rituximab

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1042819021000040044

CD20-negative relapse after (131)I-anti-CD20 therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1042819021000040044

Optimal primer selection for clonality assessment by polymerase chain reaction analysis: I. Low grade B-cell lymphoproliferative disorders of nonfollicular center cell type

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1042819021000040044

Emergence of idiotype variants during treatment of B-cell lymphoma with anti-idiotype antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1042819021000040044

10.1080/1042819021000040044

21 January 2018

Identifiers

DOI

1 reference

3 September 2017

1 reference